SCGT

SCGT is an acronym that can refer to more than one concept across different disciplines. There is no single universally accepted meaning. The intended interpretation depends on context, field, and the organization using the term.

Somatic cell gene therapy (SCGT) refers to gene therapy performed in somatic (non-reproductive) cells to treat disease. The goal is to introduce, modify, or repair genes in target tissues, producing therapeutic effects that are not inherited by future generations. This approach contrasts with germline gene therapy and has been explored in a range of conditions, including metabolic disorders and immune deficiencies.

Single-cell genomics and transcriptomics (SCGT) denotes methods and analyses focused on genomic DNA and gene expression at the level of individual cells. This field helps reveal cellular heterogeneity, developmental processes, and disease mechanisms that are obscured in bulk analyses. Techniques commonly associated with this usage include single-cell DNA sequencing and single-cell RNA sequencing.

Supercritical gas turbine (SCGT) is a term used in energy technology to describe turbine designs or research exploring operation under supercritical pressures or with supercritical carbon dioxide cycles. These concepts aim to increase efficiency and reduce emissions in power generation, often within future-orientated or experimental frameworks.

Because SCGT has multiple distinct meanings, readers should determine the intended sense from the surrounding text.